Details of the Drug-Related molecule(s) Interaction Atlas

US10030004, Compound 19 Drug Info

SCHEMBL16879133; BDBM280352; US10030004, Compound 19; Synthesis of N-(2-aminoethyl)-4-[[2-(5-chloro-2-fluoro-phenyl)-5-isopropyl-4-pyridyl]amino]pyridine-3-carboxamide

Cross-matching ID

PubChem CID

118211014

TTD Drug ID

DM0RAPC

General Information of Drug (ID: DM0RAPC)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Activin receptor type IB (ACVR1B)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
US9682983, 1	DM6EQVT	N. A.	N. A.	Patented	[2]
BDBM108945	DMZD6IJ	N. A.	N. A.	Patented	[2]
US9682983, 33	DM6R1YP	N. A.	N. A.	Patented	[2]
US10030004, Compound 33	DMD0GN6	N. A.	N. A.	Patented	[1]
US10030004, Compound 11a	DMG4T13	N. A.	N. A.	Patented	[1]
PMID23639540C13d	DMSTQGH	Discovery agent	N.A.	Investigative	[3]
PMID23639540C13r	DMHBZ0N	Discovery agent	N.A.	Investigative	[3]
------------------------------------------------------------------------------------


⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Activin receptor type IB (ACVR1B)	TTPKHTZ	ACV1B_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Compounds and methods of use. US10030004.
2	BMP inhibitors and methods of use thereof. US9682983.
3	Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe. Bioorg Med Chem Lett. 2013 Jun 1;23(11):3248-52.